# Filing Detail

Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]:
SEC Accession No. 0001437749-23-007795
Filing Date
2023-03-24
Accepted
2023-03-24 16:05:35
Documents
72
Period of Report
2022-12-31

Document Format Files

Seq | Description | Document | Type | Size
--- | --- | --- | --- | ---
1 | FORM 10-K | dffn20221231_10k.htm iXBRL | 10-K | 1374281
2 | EXHIBIT 3.1 | ex_488532.htm | EX-3.1 | 33099
3 | EXHIBIT 3.2 | ex_488533.htm | EX-3.2 | 134757
4 | EXHIBIT 10.14 | ex_489418.htm | EX-10.14 | 51485
5 | EXHIBIT 10.15 | ex_489419.htm | EX-10.15 | 49201
6 | EXHIBIT 21.1 | ex_489420.htm | EX-21.1 | 6623
7 | EXHIBIT 23.1 | ex_492494.htm | EX-23.1 | 2862
8 | EXHIBIT 31.1 | ex_482211.htm | EX-31.1 | 8910
9 | EXHIBIT 31.2 | ex_482212.htm | EX-31.2 | 8944
10 | EXHIBIT 32.1 | ex_482213.htm | EX-32.1 | 6286
16 |  | d01.jpg | GRAPHIC | 3972
17 |  | image01.jpg | GRAPHIC | 13049
18 |  | image03.jpg | GRAPHIC | 15654
19 |  | image04.jpg | GRAPHIC | 21805
| Complete submission text file | 0001437749-23-007795.txt |  | 5534570

Data Files

Seq | Description | Document | Type | Size
--- | --- | --- | --- | ---
11 | XBRL TAXONOMY EXTENSION SCHEMA | dffn-20221231.xsd | EX-101.SCH | 44809
12 | XBRL TAXONOMY EXTENSION DEFINITION LINKBASE | dffn-20221231_def.xml | EX-101.DEF | 314554
13 | XBRL TAXONOMY EXTENSION LABEL LINKBASE | dffn-20221231_lab.xml | EX-101.LAB | 274650
14 | XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE | dffn-20221231_pre.xml | EX-101.PRE | 340073
15 | XBRL TAXONOMY EXTENSION CALCULATION LINKBASE | dffn-20221231_cal.xml | EX-101.CAL | 32209
66 | EXTRACTED XBRL INSTANCE DOCUMENT | dffn20221231_10k_htm.xml | XML | 560617

Mailing Address 300 EAST MAIN STREET SUITE 201 CHARLOTTESVILLE VA 22902
Business Address 300 EAST MAIN STREET SUITE 201 CHARLOTTESVILLE VA 22902 (434) 220-0718
Diffusion Pharmaceuticals Inc. (Filer) CIK: 0001053691 (see all company filings)

EIN.: 300645032 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-K | Act: 34 | File No.: 001-37942 | Film No.: 23759887
SIC: 2834 Pharmaceutical Preparations